Clinical Trial Update: A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tolerability and efficacy of cannabidiol on tremor in Parkinson's disease. The study is completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-02-19